openPR Logo
Press release

Center for Human Reproduction More Than Doubles IVF Pregnancy Rates in Women Over 44

06-11-2012 07:38 PM CET | Health & Medicine

Press release from: Center for Human Reproduction

Center for Human Reproduction More Than Doubles IVF Pregnancy

Center for Human Reproduction (CHR), a New York fertility center with special expertise in treating women with “older-behaving” ovaries, reported significantly improved ongoing clinical pregnancy rates for 2011 at practically all age groups. The improvement was, however, most pronounced in women above age 44 years, where the rate doubled from the previous year.

Pregnancy rates are calculated by dividing the number of clinical pregnancies by that of embryo transfers. While most age groups saw increases in IVF pregnancy rates, the most dramatic improvement in pregnancy rates were observed in women at ages 44-49, where pregnancy rates increased to 10.3%.

“This pregnancy rate for women 44-49 is almost unbelievable, considering that patients at these ages, at most other IVF centers in the world, are no longer even given the chance of pregnancy with use of their own eggs and are usually advised to use donor eggs, “ notes David H. Barad, MD, Director of Clinical ART at CHR. “These results reflect our center’s fight for every egg and every embryo in older women seeking fertility treatment, based on the accumulated results of very active, decade-long research in how to successfully treat ‘older’ ovaries.”

In concentrating most of the center’s research on “older-behaving” ovaries, CHR developed many major clinical breakthroughs, like DHEA (androgen) supplementation, which has since become standard treatment around the world. CHR investigators also recently confirmed the importance of androgens (male hormones) for follicle and egg maturation.

“What makes these pregnancy rates even more remarkable are the patients in whom we achieved them,” adds Norbert Gleicher, MD, Medical Director and Chief Scientist of CHR. “As a result of premature ovarian aging (POA), even younger patients of CHR, in most cases, have ovaries that behave like those of much older women.” Dr. Gleicher continues: “The majority of our patients have previously failed IVF cycles elsewhere, and have been turned away by other fertility centers as ‘hopeless’ unless willing to use donor eggs. CHR was their fertility center of last resort. Achieving pregnancies at these rates in these women is practically unprecedented.”

About Center for Human Reproduction
The Center for Human Reproduction (CHR, http://www.centerforhumanreprod.com), is one of the world’s leading fertility centers, with, currently, over half of the center’s patients coming from outside the larger New York tristate area, approximately a quarter from overseas and Canada. CHR has a worldwide reputation as the "fertility center of last resort," specializing in treatment of infertility in women with diminished ovarian reserve due to advanced age or, in younger women, due to premature ovarian aging (POA).

Dr. Gleicher and Dr. Barad are available for further comments.

Communications Manager
Center for Human Reproduction
212-994-4400 x.4491
webadmin@thechr.com
21 E. 69th Street
New York, NY 10021

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Center for Human Reproduction More Than Doubles IVF Pregnancy Rates in Women Over 44 here

News-ID: 224295 • Views:

More Releases from Center for Human Reproduction

IVF Success Rates Not Improved by Preimplantation Genetic Screening, According to CHR Research
IVF Success Rates Not Improved by Preimplantation Genetic Screening, According t …
There is no evidence that recent technical improvements in preimplantation genetic screening (PGS) improve IVF pregnancy chances, according to a paper just published online in the Journal of Assisted Reproduction and Genetics1. The review, by two fertility specialists from New York’s Center for Human Reproduction (CHR), raises important questions, as this “new” PGS is actively marketed to patients as “proven” and “established” to increase IVF success rates. In the late ‘90s,
Research from CHR Offers Hope for Women with Treatment-Resistant Thin Endometrium
Research from CHR Offers Hope for Women with Treatment-Resistant Thin Endometriu …
November 15, 2012 (New York, NY) – Direct perfusion of the endometrial cavity with granulocyte colony-stimulating factor (G-CSF) improves the thickness of the endometrial lining in IVF patients with too thin endometrium even after treatments, according to a new study just published online in the medical journal Human Reproduction(1). In the study, 21 women undergoing in vitro fertilization (IVF) cycles at the Center for Human Reproduction (CHR) in New York City
FMR1 Gene May Control Women’s Fertility Life Cycle, According to Research
FMR1 Gene May Control Women’s Fertility Life Cycle, According to Research
October 23, 2012 (New York, NY) – A new study presented at the Annual Meeting of the American Society for Reproductive Medicine (ASRM) in San Diego, CA, offers further evidence that the fragile X mental retardation 1 gene (FMR1 gene) may play an important role in controlling women’s fertility life cycles. The study, conducted by researchers from the Center for Human Reproduction (CHR), a leading fertility center in New York
BRCA1/2 Mutation and FMR1 Gene Study Has Potential Implications for Cancer Screening and Treatment
BRCA1/2 Mutation and FMR1 Gene Study Has Potential Implications for Cancer Scree …
BRCA1/2 gene mutations, widely associated with breast and ovarian cancer risks in women, are, in principle, lethal to human embryos, according to new research conducted by three teams of researchers from the Center for Human Reproduction (CHR) in New York City, the Medical University Vienna in Vienna, Austria, and the Medical University Graz, Graz, Austria. BRCA1/2-positive embryos will only survive when also carrying a specific FMR1 gene genotype. In a paper

All 4 Releases


More Releases for CHR

Bifidobacterium Market Size | Industry Report, 2027|Chr Hansen, DSM, Yakult
LOS ANGELES, United States: The report is an all-inclusive research study of the global Bifidobacterium market taking into account the growth factors, recent trends, developments, opportunities, and competitive landscape. The market analysts and researchers have done extensive analysis of the global Bifidobacterium market with the help of research methodologies such as PESTLE and Porter’s Five Forces analysis. They have provided accurate and reliable market data and useful recommendations to help
Compound Lipase Market Foreseen to Grow Exponentially by 2028 | DSM BioSolutions …
This detailed market study covers compound lipase market growth potentials which can assist the stake holders to understand key trends and prospects in compound lipase market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the market's growth potential, which can help investors identify scope and opportunities. The
Probiotics Market In-Depth Industry Analysis 2025 Top Leading Players: Chr. Hans …
Probiotics Market report deals with the breakdown of global information by producers, application and product type while dissecting the market status, market share, market analysis, development rate, future demand trends, industry drivers, opportunities and challenges, sales channels, and wholesalers. The key factors driving the probiotics market are rising demand from functional food and dietary supplements industry and increasing health consciousness among consumers. Global probiotics market report also contains a precise
Compound Lipase Market Insights on Trends, Drivers and Opportunities by 2023 & k …
Compound Lipase Market Compound Lipase Market was valued at USD xx Million in 2017 and projected to reach USD xx Million by 2023 growing at a CAGR of 6.8% during the forecast period 2018 to 2023. Compound Lipase Market Overview: Lipase is a compound which plays crucial role in digestion process. It is a sub class of the esterase. The compound lipase is used in the applications of baking in the modern days.
Global Probiotics Market 2019 - DuPont (Danisco), Chr. Hansen, Lallemand, China- …
This new report by Eon Market Research, titled “Global Probiotics Market 2019 Research Report, 2015 – 2025” offers a comprehensive analysis of Probiotics industry at a global as well as regional and country level. Key facts analyzed in this report include the Probiotics market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025. This report primarily focuses on the study of the competitive
Carotenoids Market – Sophisticated Performance 2025 | Farbest Brands, Chr. Han …
Global Carotenoids Market: Overview Carotenoids, a class of phytonutrients, are plant pigments due to which several fruits and vegetables acquire their bright shades of red, orange, and yellow. Several algae, bacteria, and plants contain these pigments. Acting as anti-oxidants, carotenoids possess cancer-fighting properties, suggests recent research. Carotenoids also have anti-inflammatory properties, improve the immune system, and are believed to aid in the prevention of cardiovascular diseases. Some of the fruits and